Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-18

Clinical Trial Update: The Effect of Sihogayonggolmoryeo-tang on the Anxiety of Hwa-byung [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether Sihogayonggolmoryeo-tang reduces anxiety in individuals with Hwa-byung; current status/results are not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sihogayonggolmoryeo-tang

Snippet

Sponsor: Korea Health Industry Development Institute | Conditions: Hwa-byung | Phase 4 | Status: UNKNOWN